References
Fahle GA, Gill VJ, Fischer SH (1999). Optimal activation of isopsoralen to prevent amplicon carryover. J Clin Micorbiol, 37: 261–262.
Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA (1997). Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet 349: 241–244.
Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L (1991). The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology, 41, 479–486.
Pevenstein SR, Williams RK, McChesney D, Mont EK, Smialek JE, Straus SE (1999). Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J. Virol, 73: 10514–10518.
Tsuang D, Kukull W, Sheppard L, Barnhart RL, Peskind E, Edland SD, Schellenberg G, Raskind M, Larson EB (1996). Impact of sample selection on APOE epsilon 4 allele frequency: a comparison of two Alzheimer’s disease samples. J Am Geriatr Soc, 44: 704–707.
Wu YY, Delgado R, Costello R, Sunderland T, Dukoff R, Csako G (2000). Quantitative assessment of apolipoprotein E genotypes by image analysis of PCR-RFLP fragments. Clin Chim Acta, 293: 213–221.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marques, A.R., Straus, S.E., Fahle, G. et al. Lack of association between HSV-1 DNA in the brain, Alzheimer’s disease and apolipoprotein E4. Journal of NeuroVirology 7, 82–83 (2001). https://doi.org/10.1080/135502801300069773
Issue Date:
DOI: https://doi.org/10.1080/135502801300069773